All In Biotech

Drug Trial Radar · NCT00115648

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

Last checked: Nov 20, 2026Latest source record: Mar 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 3,300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,300

Planned (sponsor's estimate)

Start

Apr 2004

Primary completion

Aug 2007

Study completion Oct 2009

Sponsor

Lead sponsor
Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Centers for Disease Control and Prevention; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Jun 24, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 54 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if extended antiretroviral regimens given to the infant during the first 14 weeks of age would decrease breast milk transmission of HIV.

Conditions

  • HIV Infections

Interventions

  • NevirapineDrug

    Oral NVP daily dosage

  • AZTDrug

    Oral AZT daily

  • NVP and AZTDrug

    Oral single dose NVP plus oral daily AZT during the first weeks

  • NVPDrug

    Oral NVP daily to age 14 weeks

  • NVP+AZTDrug

    Oral NVP daily plus oral AZT daly to age 14 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A. Rate of HIV infection at 9 months and assess HIV infection rates at 6-8 & 14 weeks, and 6, 12, 18, and 24 months. B.Determine HIV survival rates at ages 6, 12, 18, and 24 months. C. Evaluate safety of oral NVP and ZDV for 14 weeks.Time frame: 9 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • College of Medicine

    Blantyre, Malawi

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.